Overview

Safety Study of SPC3649 in Healthy Men

Status:
Completed

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Summary

A placebo-controlled, double-blind, randomized, single dose, dose escalating trial in healthy men to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPC3649.

Phase:

Phase 1

Details

Lead Sponsor:

Santaris Pharma A/S